MedTrace Logo

Evaluating a Host-response Based Diagnostic for Distinguishing Between Bacterial and Viral Etiology in Patients With Lower Respiratory Tract Infection (LRTI)

NCT03011515 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 583

Last updated 2021-10-12

No results posted yet for this study

Summary

The purpose of this study is to validate the diagnostic accuracy of a novel host-response based diagnostic tool for differentiating between bacterial and viral etiologies in adult patients aged 18 years and older with clinical suspicion of lower respiratory tract infections (LRTI)

Conditions

Sponsors & Collaborators

  • Rambam Health Care Campus

    collaborator OTHER

  • Carmel Medical Center

    collaborator OTHER

  • Rabin Medical Center

    collaborator OTHER

  • European Commission

    collaborator OTHER

  • MeMed Diagnostics Ltd.

    lead INDUSTRY

Principal Investigators

  • Mical Paul, MD · Rambam Health Care Campus

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-10
Primary Completion
2018-01-01
Completion
2020-01-07

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03011515 on ClinicalTrials.gov